75 related articles for article (PubMed ID: 7551239)
1. Stearyl tyrosine. An organic equivalent of aluminum-based immunoadjuvants.
Penney C
Pharm Biotechnol; 1995; 6():611-24. PubMed ID: 7551239
[No Abstract] [Full Text] [Related]
2. Further studies on the adjuvanticity of stearyl tyrosine and ester analogues.
Penney CL; Ethier D; Dionne G; Nixon-George A; Zaghouani H; Michon F; Jennings H; Bona CA
Vaccine; 1993; 11(11):1129-34. PubMed ID: 8249432
[TBL] [Abstract][Full Text] [Related]
3. The interaction of slow-release immunoadjuvants with selected antigens measured in vitro.
Penney C; Shah P; Landi S
J Biol Stand; 1985 Jan; 13(1):43-52. PubMed ID: 3988778
[TBL] [Abstract][Full Text] [Related]
4. Preformulation studies--The next advance in aluminum adjuvant-containing vaccines.
Hem SL; HogenEsch H; Middaugh CR; Volkin DB
Vaccine; 2010 Jul; 28(31):4868-70. PubMed ID: 20488265
[No Abstract] [Full Text] [Related]
5. Aluminium adjuvants--in retrospect and prospect.
Lindblad EB
Vaccine; 2004 Sep; 22(27-28):3658-68. PubMed ID: 15315845
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvants for human vaccines].
Bröker M; Beyer C
Pharm Unserer Zeit; 2008; 37(1):42-51. PubMed ID: 18081081
[No Abstract] [Full Text] [Related]
7. Further studies on the adjuvanticity of stearyl tyrosine and amide analogues.
Penney CL; Dionne G; Nixon-George A; Bona CA
Vaccine; 1994 May; 12(7):629-32. PubMed ID: 8085381
[TBL] [Abstract][Full Text] [Related]
8. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.
Sokolovska A; Hem SL; HogenEsch H
Vaccine; 2007 Jun; 25(23):4575-85. PubMed ID: 17485153
[TBL] [Abstract][Full Text] [Related]
9. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
Hem SL; Hogenesch H
Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
Berthold I; Pombo ML; Wagner L; Arciniega JL
Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073
[TBL] [Abstract][Full Text] [Related]
12. An aluminium adjuvant in a vaccine is an acute exposure to aluminium.
Exley C
J Trace Elem Med Biol; 2020 Jan; 57():57-59. PubMed ID: 31561170
[No Abstract] [Full Text] [Related]
13. Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine.
Bovier PA; Farinelli T; Loutan L
Vaccine; 2005 Mar; 23(19):2424-9. PubMed ID: 15752828
[TBL] [Abstract][Full Text] [Related]
14. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
15. Vaccine immunopotentiators of the future.
Schijns VE; Degen WG
Clin Pharmacol Ther; 2007 Dec; 82(6):750-5. PubMed ID: 17914440
[TBL] [Abstract][Full Text] [Related]
16. Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.
Ophorst OJ; Radosević K; Klap JM; Sijtsma J; Gillissen G; Mintardjo R; van Ooij MJ; Holterman L; Companjen A; Goudsmit J; Havenga MJ
Vaccine; 2007 Aug; 25(35):6501-10. PubMed ID: 17646036
[TBL] [Abstract][Full Text] [Related]
17. Immunological adjuvants and their modes of action.
Allison AC
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):141-7. PubMed ID: 9597079
[TBL] [Abstract][Full Text] [Related]
18. Review of L-tyrosine confirming its safe human use as an adjuvant.
Baldrick P; Richardson D; Wheeler AW
J Appl Toxicol; 2002; 22(5):333-44. PubMed ID: 12355563
[TBL] [Abstract][Full Text] [Related]
19. Influenza A (H5N1) pandemic prototype vaccine Fluval.
Vajo Z
Expert Rev Vaccines; 2009 May; 8(5):619-24. PubMed ID: 19397418
[TBL] [Abstract][Full Text] [Related]
20. (How) do aluminium adjuvants work?
Brewer JM
Immunol Lett; 2006 Jan; 102(1):10-5. PubMed ID: 16188325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
